Remedy Meds, LLC is acquiring Thirty Madison, Inc. for over $500 million to create a multi-brand telehealth platform that enhances access to specialized care across multiple health categories.

Information on the Target

Remedy Meds, LLC is a leading consumer virtual-care and pharmacy platform dedicated to enhancing patient access to specialized health treatments. The company has announced a definitive agreement to acquire Thirty Madison, Inc., which provides a unique end-to-end virtual care service targeting a range of health conditions. This deal aims to establish a comprehensive, multi-brand health platform that spans women’s health, men’s health, and metabolic care.

Valued at over $500 million, the transaction will be executed through an all-stock deal. The acquisition is expected to close in the fourth quarter of 2025, contingent upon customary closing conditions and regulatory approvals.

Industry Overview

The virtual healthcare industry has experienced rapid growth, particularly in the United States, driven by increased demand for accessible and affordable healthcare solutio